Valeant Pharmaceuticals
Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees
Valeant Pharmaceuticals is a pharmaceutical manufacturing company based in Bridgewater, New Jersey. It has grown through a series of acquisitions and product introductions, including the 2013 purchase of Bausch + Lomb and subsequent product launches tied to Sprout Pharmaceuticals, such as Addyi in the U.S. market. The company has also expanded its consumer dermatology footprint through the acquisition of AcneFree in 2012. Public reporting has highlighted investigations into accounting and pricing practices and related legal actions involving former executives. The Valeant LinkedIn page has been discontinued, with updates now posted on the Bausch Health Companies page.